A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

• Status: Completed
• Trial end date: 2013-02-01

Summary

This is a study of itacitinib in patients with chronic plaque psoriasis. This study will evaluate safety and efficacy parameters of itacitinib.

• Phase: Phase 2

Details

• Lead Sponsor: Incyte Corporation